Physiologas Secures Funding from Hokuhoku Capital for Home Hemodialysis
NQ Score
0/100
N1 Content Completeness
9
Key facts
- Physiologas Secures Funding from Hokuhoku Capital for Home Hemodialysis
- Physiologas Technologies Co., Ltd. has completed a Series A fourth close funding round by the end of May 2026, with Hokuhoku Capital Co., Ltd. and individual investors as new subscribers. The funds will be used for the design, development, prototyping, and non-clinical testing of home hemodialysis devices and consumables.
- Source: PR TIMES
- Date: Tue Jun 09 2026 10:00:03 GMT+0900 (Japan Standard Time)
Direct answer
Physiologas Technologies Co., Ltd. has completed a Series A fourth close funding round by the end of May 2026, with Hokuhoku Capital Co., Ltd. and individual investors as new subscribers. The funds will be used for the design, development, prototyping, and non-clinical testing of home hemodialysis devices and consumables.
- Citation
- Physiologas Secures Funding from Hokuhoku Capital for Home Hemodialysis (Tue Jun 09 2026 10:00:03 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Tue Jun 09 2026 10:00:03 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Physiologas Technologies Co., Ltd. has completed a Series A fourth close funding round by the end of May 2026, with Hokuhoku Capital Co., Ltd. and individual investors as new subscribers. The funds will be used for the design, development, prototyping, and non-clinical testing of home hemodialysis devices and consumables.
AI Analysis
Frequently Asked Questions
- Q: Where is Physiologas Technologies headquartered?
- A: At 1-15-1 Kitasato, Minami-ku, Sagamihara City, Kanagawa Prefecture, within Kitasato University Sagamihara Campus.
- Q: Who is the CEO of Physiologas Technologies?
- A: Kazuyoshi Miyawaki serves as the Representative Director.
- Q: Who were the subscribers in this funding round?
- A: Hokuhoku Capital Co., Ltd. and individual investors.